Detroit-based Barbara Ann Karmanos Cancer Institute has become the first independent cancer center in the U.S. to provide a one-time gene therapy for the treatment of hemophilia B in adults. The first patient received the therapy — called Hemgenix —…
Pharmacy
Pfizer and Valneva’s investigational Lyme disease vaccine candidate, PF-07307405 (LB6V), demonstrated more than 70% efficacy in preventing Lyme disease among individuals age 5 and older, according to topline phase 3 trial results. The prespecified analysis showed 74.8% efficacy starting one…
Bristol Myers Squibb has received two expanded U.S. approvals for Opdivo (nivolumab) combinations that establish additional immunotherapy options for classical Hodgkin lymphoma across pediatric and adult populations. The FDA approved Opdivo in combination with doxorubicin, vinblastine and dacarbazine (AVD) for…
The Institute for Safe Medication Practices outlined 15 strategies for reducing medication errors in clinical settings in its 2026-2027 “Targeted Medication Safety Best Practices for Hospitals.” The update includes three new best practices and 12 carried forward from previous cycles.…
The FDA will hold a public hearing June 12 to gather feedback on its Commissioner’s National Priority Voucher pilot program. The hearing will be held at the agency’s White Oak campus in Silver Spring, Md., with options to attend virtually,…
Advertisement
CSL, a global biotechnology company, is experiencing a temporary worldwide stockout of Hemgenix (etranacogene dezaparvovec-drlb), its one-time gene therapy for adults with hemophilia B. The shortage will delay treatment for some patients in countries where the therapy is commercially available,…
Kenny Yu, PharmD, has been named senior vice president and chief pharmacy officer at New York City-based Mount Sinai Health System, according to a March 21 LinkedIn post. Dr. Yu joins the system from NYU Langone Health, where he spent…
The federal direct-to-consumer website TrumpRx.gov currently lists 54 brand-name medications accessible through manufacturer-run cash discount programs. That number is expected to grow, as the White House plans to add three additional therapies from Boehringer Ingelheim, according to a March 20…
Artificial intelligence is gaining traction across hospital pharmacy operations, but many health systems struggle to move beyond small pilot programs. According to Bickkie Solomon, PharmD, director of pharmacy at HCA Florida North Florida Hospital, part of Nashville, Tenn.-based HCA Healthcare,…
The American Society of Health-System Pharmacists has appointed Samuel Calabrese as executive vice president and CEO, effective May 1. Mr. Calabrese will become the fifth CEO in the organization’s 84-year history, succeeding Paul Abramowitz, PharmD, who retired earlier this year,…